目的分析规范化支气管哮喘(哮喘)管理对住院哮喘患者的效果。
方法回顾性分析2008年1月1日到2017年12月31日在北部战区总医院呼吸内科与变态反应疾病诊治中心住院的2 207例次哮喘患者的临床资料。
结果10年住院哮喘患者占同期住院患者的11.5%(2 207/19 134),2008年最高(16.9%,207/1 223),之后下降,2009—2013年中位数为13.2%(221/1 674),2014—2017年中位数为9.4%(224/2 385),2009—2017年与2008年比较差异均有统计学意义(均 P<0.05)。10年期间住院1次的哮喘患者占69.1%(1 526/2 207),住院2次占13.3%(294/2 207),住院2次以上占3.8%(85/2 207);因哮喘急性加重入院患者1 553例,占同期住院患者的8.1%(1 553/19 134),2008年最高,为14.2%(174/1 223),之后下降,2009—2013年中位数为9.7%(163/1 674),2014—2017年中位数为5.9%(141/2 385),2009—2017年与2008年比较差异均有统计学意义(均 P<0.05)。因哮喘共患疾病急性加重入院的患者占所有哮喘患者百分比2008年最低,为15.9%(33/207),总体呈现增加趋势,2009—2013年中位数为25.8%(58/221),2014—2017年中位数为37.0%(83/224)。哮喘急性加重住院月份:占9.2%(150/1 628)的3月和占9.7%(157/1 612)的8月是哮喘急性加重入院高峰月,和患者入院最少占7.1%(101/1 423)的2月进行比较,差异有统计学意义( P<0.05);其他月份与2月比,差异无统计学意义( P<0.05);哮喘急性加重住院1次占69.2%(1 074/1 553)。将哮喘急性加重住院患者分为多次组(住院≥2次,479例)和1次组(1 074例),发现多次组危险因素为感染诱发( OR:2.006),男性( OR:1.355),年龄≥ 65岁( OR:1.364),体检有湿啰音( OR:1.762),住院天数≥14 d( OR:1.892)和行有创机械通气( OR:1.798)。哮喘反复住院患者的人均费用为(16 219±16 628,681例)元,与单次住院患者人均费用[(13 752±20 692, n=1 526)元]比较、哮喘急性加重反复住院患者的人均费用为(13 933±13 036, n=479)元,与单次哮喘急性加重住院患者人均费用[(11 208±13 853,1 074例)元]比较、哮喘反复住院患者(681例)和哮喘急性加重反复住院患者(479例)比较、哮喘单次住院患者(1 526例)与哮喘急性加重单次住院患者(1 074例)比较,差异均有统计学意义( P<0.05)。
结论哮喘规范化管理可减少哮喘患者住院次数,哮喘规范化管理应关注哮喘急性加重反复住院的危险因素。
ObjectiveTo analyze the outcome of standardized management on the hospitalized asthmatic patients in the past 10 years in a single center.
MethodsClinical data of 2 207 asthmatic patients, who were hospitalized in the Center of Respiratory Medicine and Allergic Diseases, the General Hospital of Northern Military District from January 1, 2008 to December 31, 2017, was retrospectively collected and analyzed.
ResultsAsthmatic in-patients accounted for 11.5% of total hospitalized patients(2 207/19 134) over the 10-year study period. The highest percentage of asthmatic patients over the total hospitalized patients (16.9%, 207/1 223) was in the year 2008, and it was gradually reduced from 2009 through 2017: a median of 13.2% (221/1 674) from 2009 to 2013 with 3.7% decrease, and a median of 9.4% (224/2 385) from 2014 to 2017 with 7.5% decrease. There was a significant difference in the percentages between the year of 2008 (16.9%) and the years from 2009 through 2017 ( P<0.05). Over the 10-year study period, 69.1% (1 526/2 207) of the asthmatic in-patients were hospitalized only once, 13.3% (294/2 207) were twice, and 3.8% (85/2 207) were hospitalized more than twice. Totally 1,553 patients were hospitalized with acute asthmatic attack, which accounted for 8.1% (1 553/19 134) of the total in-patient number over the 10 years, and 14.2% (174/1 223) of which was in the year 2008, while 9.7% (163/1 674) was in the years from 2009 through 2013 with a decrease of 4.5% from 2008, and 5.9% (141/2 385) was in 2014 through 2017 with a decrease of 8.3% from 2008. The differences between the 2008 incidence and that of 2009—2013 or 2014—2017 were statistically significant ( P<0.05). However, the incidence of acute exacerbation of comorbid conditions was lowest in 2008 (15.9%, 33/207), while it was 25.8% (58/221) from 2009 to 2013 with an increase of 9.9% from 2008, and 37.0% (83/224) from 2013 to 2017 with an increase of 21.1% compared to 2008. Asthmatic hospitalization peaked in March (9.2%, 150/1 628) and August (9.7%, 157/1 612), respectively, while it was lowest in February (7.1%,101/1 423). The difference between the peak months (March and August) and February was statistically significant ( P<0.05), while there was no significant difference between February and the rest of months ( P>0.05). When the risk factors for acute asthmatic attack was analyzed by grouping single-time attack ( n=1 074) versus multiple-time attack (hospitalized ≥ 2 times, n=479), we found the following risk factors were significant: airway infection ( OR=2.006), male ( OR=1.355), age ≥ 65 years old ( OR=1.364), wet rales on physical examination ( OR=1.762), hospitalization ≥ 14 days ( OR=1.892), and invasive mechanical ventilation ( OR=1.798). In addition, there were significant differences in per capital cost comparison between the following pairs ( P<0.05): multiple-time (16 219±16 628, n=681) vs single-time asthmatic hospitalization (13 752±20 692, n=1 526), multiple-time (13 933±13 036, n=479) vs single-time hospitalization with acute asthmatic attack (11 208±13 853, n=1 074), multi-time asthmatic hospitalization ( n=681) vs multi-time hospitalization with acute asthmatic attack ( n=479), and single-time asthmatic hospitalization ( n=1 526) vs single-time hospitalization with acute asthmatic attack ( n=1 074).
ConclusionsStandardized management of asthma could significantly reduce the risk of hospitalization as well as acute asthmatic attack. Findings of the current study suggested that risk factors for acute and recurrent asthmatic attack should be assessed and managed efficiently in order to reduce incidence of multiple hospitalization for asthma.
谢华,陈萍,张志远,等. 施行规范化管理10年单中心住院支气管哮喘患者调查结果分析[J]. 中华结核和呼吸杂志,2019,42(3):179-184.
DOI:10.3760/cma.j.issn.1001-0939.2019.03.007版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。
除非特别声明,本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。